Tumor-infiltrating lymphocytes can be activated in situ by using in vivo activants plus F(ab')2 bispecific antibodies. [electronic resource]
Producer: 19960916Description: 232-7 p. digitalISSN:- 0020-7136
- Animals
- Antibodies, Bispecific -- pharmacology
- Cricetinae
- Cytotoxicity, Immunologic
- Enterotoxins -- pharmacology
- Glucans -- pharmacology
- Immunoglobulin Fab Fragments -- pharmacology
- Lymphocyte Activation -- drug effects
- Lymphocytes, Tumor-Infiltrating -- immunology
- Melanoma, Experimental -- immunology
- Mice
- Mice, Inbred C3H
- Neoplasm Transplantation
- T-Lymphocytes, Cytotoxic -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.